Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Legalized Cannabis Market Growth 2022-2028

  • LP 4787514
  • 94 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Legalized Cannabis will have significant change from previous year. According to our (LP Information) latest study, the global Legalized Cannabis market size is USD million in 2022 from USD 19480 million in 2021, with a change of % between 2021 and 2022. The global Legalized Cannabis market size will reach USD 38370 million in 2028, growing at a CAGR of 10.2% over the analysis period.

The United States Legalized Cannabis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Legalized Cannabis market, reaching US$ million by the year 2028. As for the Europe Legalized Cannabis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Legalized Cannabis players cover Dixie Elixirs, Cronos Group, Canopy Growth, and Aurora Cannabis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Legalized Cannabis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Cannabis Herb

Cannabis Resin

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Entertainment Venue

Medical Institutions

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Dixie Elixirs

Cronos Group

Canopy Growth

Aurora Cannabis

ABcann Medicinals

Aphria

Maricann Group

ABcann Medicinals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Legalized Cannabis Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Legalized Cannabis by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Legalized Cannabis by Country/Region, 2017, 2022 & 2028

2.2 Legalized Cannabis Segment by Type

2.2.1 Cannabis Herb

2.2.2 Cannabis Resin

2.2.3 Other

2.3 Legalized Cannabis Sales by Type

2.3.1 Global Legalized Cannabis Sales Market Share by Type (2017-2022)

2.3.2 Global Legalized Cannabis Revenue and Market Share by Type (2017-2022)

2.3.3 Global Legalized Cannabis Sale Price by Type (2017-2022)

2.4 Legalized Cannabis Segment by Application

2.4.1 Entertainment Venue

2.4.2 Medical Institutions

2.4.3 Other

2.5 Legalized Cannabis Sales by Application

2.5.1 Global Legalized Cannabis Sale Market Share by Application (2017-2022)

2.5.2 Global Legalized Cannabis Revenue and Market Share by Application (2017-2022)

2.5.3 Global Legalized Cannabis Sale Price by Application (2017-2022)

3 Global Legalized Cannabis by Company

3.1 Global Legalized Cannabis Breakdown Data by Company

3.1.1 Global Legalized Cannabis Annual Sales by Company (2020-2022)

3.1.2 Global Legalized Cannabis Sales Market Share by Company (2020-2022)

3.2 Global Legalized Cannabis Annual Revenue by Company (2020-2022)

3.2.1 Global Legalized Cannabis Revenue by Company (2020-2022)

3.2.2 Global Legalized Cannabis Revenue Market Share by Company (2020-2022)

3.3 Global Legalized Cannabis Sale Price by Company

3.4 Key Manufacturers Legalized Cannabis Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Legalized Cannabis Product Location Distribution

3.4.2 Players Legalized Cannabis Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Legalized Cannabis by Geographic Region

4.1 World Historic Legalized Cannabis Market Size by Geographic Region (2017-2022)

4.1.1 Global Legalized Cannabis Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Legalized Cannabis Annual Revenue by Geographic Region

4.2 World Historic Legalized Cannabis Market Size by Country/Region (2017-2022)

4.2.1 Global Legalized Cannabis Annual Sales by Country/Region (2017-2022)

4.2.2 Global Legalized Cannabis Annual Revenue by Country/Region

4.3 Americas Legalized Cannabis Sales Growth

4.4 APAC Legalized Cannabis Sales Growth

4.5 Europe Legalized Cannabis Sales Growth

4.6 Middle East & Africa Legalized Cannabis Sales Growth

5 Americas

5.1 Americas Legalized Cannabis Sales by Country

5.1.1 Americas Legalized Cannabis Sales by Country (2017-2022)

5.1.2 Americas Legalized Cannabis Revenue by Country (2017-2022)

5.2 Americas Legalized Cannabis Sales by Type

5.3 Americas Legalized Cannabis Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Legalized Cannabis Sales by Region

6.1.1 APAC Legalized Cannabis Sales by Region (2017-2022)

6.1.2 APAC Legalized Cannabis Revenue by Region (2017-2022)

6.2 APAC Legalized Cannabis Sales by Type

6.3 APAC Legalized Cannabis Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Legalized Cannabis by Country

7.1.1 Europe Legalized Cannabis Sales by Country (2017-2022)

7.1.2 Europe Legalized Cannabis Revenue by Country (2017-2022)

7.2 Europe Legalized Cannabis Sales by Type

7.3 Europe Legalized Cannabis Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Legalized Cannabis by Country

8.1.1 Middle East & Africa Legalized Cannabis Sales by Country (2017-2022)

8.1.2 Middle East & Africa Legalized Cannabis Revenue by Country (2017-2022)

8.2 Middle East & Africa Legalized Cannabis Sales by Type

8.3 Middle East & Africa Legalized Cannabis Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Legalized Cannabis

10.3 Manufacturing Process Analysis of Legalized Cannabis

10.4 Industry Chain Structure of Legalized Cannabis

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Legalized Cannabis Distributors

11.3 Legalized Cannabis Customer

12 World Forecast Review for Legalized Cannabis by Geographic Region

12.1 Global Legalized Cannabis Market Size Forecast by Region

12.1.1 Global Legalized Cannabis Forecast by Region (2023-2028)

12.1.2 Global Legalized Cannabis Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Legalized Cannabis Forecast by Type

12.7 Global Legalized Cannabis Forecast by Application

13 Key Players Analysis

13.1 Dixie Elixirs

13.1.1 Dixie Elixirs Company Information

13.1.2 Dixie Elixirs Legalized Cannabis Product Offered

13.1.3 Dixie Elixirs Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Dixie Elixirs Main Business Overview

13.1.5 Dixie Elixirs Latest Developments

13.2 Cronos Group

13.2.1 Cronos Group Company Information

13.2.2 Cronos Group Legalized Cannabis Product Offered

13.2.3 Cronos Group Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cronos Group Main Business Overview

13.2.5 Cronos Group Latest Developments

13.3 Canopy Growth

13.3.1 Canopy Growth Company Information

13.3.2 Canopy Growth Legalized Cannabis Product Offered

13.3.3 Canopy Growth Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Canopy Growth Main Business Overview

13.3.5 Canopy Growth Latest Developments

13.4 Aurora Cannabis

13.4.1 Aurora Cannabis Company Information

13.4.2 Aurora Cannabis Legalized Cannabis Product Offered

13.4.3 Aurora Cannabis Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Aurora Cannabis Main Business Overview

13.4.5 Aurora Cannabis Latest Developments

13.5 ABcann Medicinals

13.5.1 ABcann Medicinals Company Information

13.5.2 ABcann Medicinals Legalized Cannabis Product Offered

13.5.3 ABcann Medicinals Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 ABcann Medicinals Main Business Overview

13.5.5 ABcann Medicinals Latest Developments

13.6 Aphria

13.6.1 Aphria Company Information

13.6.2 Aphria Legalized Cannabis Product Offered

13.6.3 Aphria Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Aphria Main Business Overview

13.6.5 Aphria Latest Developments

13.7 Maricann Group

13.7.1 Maricann Group Company Information

13.7.2 Maricann Group Legalized Cannabis Product Offered

13.7.3 Maricann Group Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Maricann Group Main Business Overview

13.7.5 Maricann Group Latest Developments

13.8 ABcann Medicinals

13.8.1 ABcann Medicinals Company Information

13.8.2 ABcann Medicinals Legalized Cannabis Product Offered

13.8.3 ABcann Medicinals Legalized Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 ABcann Medicinals Main Business Overview

13.8.5 ABcann Medicinals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Legalized Cannabis Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Legalized Cannabis Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cannabis Herb

Table 4. Major Players of Cannabis Resin

Table 5. Major Players of Other

Table 6. Global Legalized Cannabis Sales by Type (2017-2022) & (MT)

Table 7. Global Legalized Cannabis Sales Market Share by Type (2017-2022)

Table 8. Global Legalized Cannabis Revenue by Type (2017-2022) & ($ million)

Table 9. Global Legalized Cannabis Revenue Market Share by Type (2017-2022)

Table 10. Global Legalized Cannabis Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Legalized Cannabis Sales by Application (2017-2022) & (MT)

Table 12. Global Legalized Cannabis Sales Market Share by Application (2017-2022)

Table 13. Global Legalized Cannabis Revenue by Application (2017-2022)

Table 14. Global Legalized Cannabis Revenue Market Share by Application (2017-2022)

Table 15. Global Legalized Cannabis Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Legalized Cannabis Sales by Company (2020-2022) & (MT)

Table 17. Global Legalized Cannabis Sales Market Share by Company (2020-2022)

Table 18. Global Legalized Cannabis Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Legalized Cannabis Revenue Market Share by Company (2020-2022)

Table 20. Global Legalized Cannabis Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Legalized Cannabis Producing Area Distribution and Sales Area

Table 22. Players Legalized Cannabis Products Offered

Table 23. Legalized Cannabis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Legalized Cannabis Sales by Geographic Region (2017-2022) & (MT)

Table 27. Global Legalized Cannabis Sales Market Share Geographic Region (2017-2022)

Table 28. Global Legalized Cannabis Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Legalized Cannabis Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Legalized Cannabis Sales by Country/Region (2017-2022) & (MT)

Table 31. Global Legalized Cannabis Sales Market Share by Country/Region (2017-2022)

Table 32. Global Legalized Cannabis Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Legalized Cannabis Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Legalized Cannabis Sales by Country (2017-2022) & (MT)

Table 35. Americas Legalized Cannabis Sales Market Share by Country (2017-2022)

Table 36. Americas Legalized Cannabis Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Legalized Cannabis Revenue Market Share by Country (2017-2022)

Table 38. Americas Legalized Cannabis Sales by Type (2017-2022) & (MT)

Table 39. Americas Legalized Cannabis Sales Market Share by Type (2017-2022)

Table 40. Americas Legalized Cannabis Sales by Application (2017-2022) & (MT)

Table 41. Americas Legalized Cannabis Sales Market Share by Application (2017-2022)

Table 42. APAC Legalized Cannabis Sales by Region (2017-2022) & (MT)

Table 43. APAC Legalized Cannabis Sales Market Share by Region (2017-2022)

Table 44. APAC Legalized Cannabis Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Legalized Cannabis Revenue Market Share by Region (2017-2022)

Table 46. APAC Legalized Cannabis Sales by Type (2017-2022) & (MT)

Table 47. APAC Legalized Cannabis Sales Market Share by Type (2017-2022)

Table 48. APAC Legalized Cannabis Sales by Application (2017-2022) & (MT)

Table 49. APAC Legalized Cannabis Sales Market Share by Application (2017-2022)

Table 50. Europe Legalized Cannabis Sales by Country (2017-2022) & (MT)

Table 51. Europe Legalized Cannabis Sales Market Share by Country (2017-2022)

Table 52. Europe Legalized Cannabis Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Legalized Cannabis Revenue Market Share by Country (2017-2022)

Table 54. Europe Legalized Cannabis Sales by Type (2017-2022) & (MT)

Table 55. Europe Legalized Cannabis Sales Market Share by Type (2017-2022)

Table 56. Europe Legalized Cannabis Sales by Application (2017-2022) & (MT)

Table 57. Europe Legalized Cannabis Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Legalized Cannabis Sales by Country (2017-2022) & (MT)

Table 59. Middle East & Africa Legalized Cannabis Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Legalized Cannabis Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Legalized Cannabis Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Legalized Cannabis Sales by Type (2017-2022) & (MT)

Table 63. Middle East & Africa Legalized Cannabis Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Legalized Cannabis Sales by Application (2017-2022) & (MT)

Table 65. Middle East & Africa Legalized Cannabis Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Legalized Cannabis

Table 67. Key Market Challenges & Risks of Legalized Cannabis

Table 68. Key Industry Trends of Legalized Cannabis

Table 69. Legalized Cannabis Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Legalized Cannabis Distributors List

Table 72. Legalized Cannabis Customer List

Table 73. Global Legalized Cannabis Sales Forecast by Region (2023-2028) & (MT)

Table 74. Global Legalized Cannabis Sales Market Forecast by Region

Table 75. Global Legalized Cannabis Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Legalized Cannabis Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Legalized Cannabis Sales Forecast by Country (2023-2028) & (MT)

Table 78. Americas Legalized Cannabis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Legalized Cannabis Sales Forecast by Region (2023-2028) & (MT)

Table 80. APAC Legalized Cannabis Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Legalized Cannabis Sales Forecast by Country (2023-2028) & (MT)

Table 82. Europe Legalized Cannabis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Legalized Cannabis Sales Forecast by Country (2023-2028) & (MT)

Table 84. Middle East & Africa Legalized Cannabis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Legalized Cannabis Sales Forecast by Type (2023-2028) & (MT)

Table 86. Global Legalized Cannabis Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Legalized Cannabis Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Legalized Cannabis Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Legalized Cannabis Sales Forecast by Application (2023-2028) & (MT)

Table 90. Global Legalized Cannabis Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Legalized Cannabis Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Legalized Cannabis Revenue Market Share Forecast by Application (2023-2028)

Table 93. Dixie Elixirs Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 94. Dixie Elixirs Legalized Cannabis Product Offered

Table 95. Dixie Elixirs Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. Dixie Elixirs Main Business

Table 97. Dixie Elixirs Latest Developments

Table 98. Cronos Group Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 99. Cronos Group Legalized Cannabis Product Offered

Table 100. Cronos Group Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Cronos Group Main Business

Table 102. Cronos Group Latest Developments

Table 103. Canopy Growth Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 104. Canopy Growth Legalized Cannabis Product Offered

Table 105. Canopy Growth Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Canopy Growth Main Business

Table 107. Canopy Growth Latest Developments

Table 108. Aurora Cannabis Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 109. Aurora Cannabis Legalized Cannabis Product Offered

Table 110. Aurora Cannabis Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. Aurora Cannabis Main Business

Table 112. Aurora Cannabis Latest Developments

Table 113. ABcann Medicinals Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 114. ABcann Medicinals Legalized Cannabis Product Offered

Table 115. ABcann Medicinals Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. ABcann Medicinals Main Business

Table 117. ABcann Medicinals Latest Developments

Table 118. Aphria Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 119. Aphria Legalized Cannabis Product Offered

Table 120. Aphria Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Aphria Main Business

Table 122. Aphria Latest Developments

Table 123. Maricann Group Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 124. Maricann Group Legalized Cannabis Product Offered

Table 125. Maricann Group Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. Maricann Group Main Business

Table 127. Maricann Group Latest Developments

Table 128. ABcann Medicinals Basic Information, Legalized Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 129. ABcann Medicinals Legalized Cannabis Product Offered

Table 130. ABcann Medicinals Legalized Cannabis Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. ABcann Medicinals Main Business

Table 132. ABcann Medicinals Latest Developments

List of Figures

Figure 1. Picture of Legalized Cannabis

Figure 2. Legalized Cannabis Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Legalized Cannabis Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Legalized Cannabis Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Legalized Cannabis Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cannabis Herb

Figure 10. Product Picture of Cannabis Resin

Figure 11. Product Picture of Other

Figure 12. Global Legalized Cannabis Sales Market Share by Type in 2021

Figure 13. Global Legalized Cannabis Revenue Market Share by Type (2017-2022)

Figure 14. Legalized Cannabis Consumed in Entertainment Venue

Figure 15. Global Legalized Cannabis Market: Entertainment Venue (2017-2022) & (MT)

Figure 16. Legalized Cannabis Consumed in Medical Institutions

Figure 17. Global Legalized Cannabis Market: Medical Institutions (2017-2022) & (MT)

Figure 18. Legalized Cannabis Consumed in Other

Figure 19. Global Legalized Cannabis Market: Other (2017-2022) & (MT)

Figure 20. Global Legalized Cannabis Sales Market Share by Application (2017-2022)

Figure 21. Global Legalized Cannabis Revenue Market Share by Application in 2021

Figure 22. Legalized Cannabis Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Legalized Cannabis Revenue Market Share by Company in 2021

Figure 24. Global Legalized Cannabis Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Legalized Cannabis Revenue Market Share by Geographic Region in 2021

Figure 26. Global Legalized Cannabis Sales Market Share by Region (2017-2022)

Figure 27. Global Legalized Cannabis Revenue Market Share by Country/Region in 2021

Figure 28. Americas Legalized Cannabis Sales 2017-2022 (MT)

Figure 29. Americas Legalized Cannabis Revenue 2017-2022 ($ Millions)

Figure 30. APAC Legalized Cannabis Sales 2017-2022 (MT)

Figure 31. APAC Legalized Cannabis Revenue 2017-2022 ($ Millions)

Figure 32. Europe Legalized Cannabis Sales 2017-2022 (MT)

Figure 33. Europe Legalized Cannabis Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Legalized Cannabis Sales 2017-2022 (MT)

Figure 35. Middle East & Africa Legalized Cannabis Revenue 2017-2022 ($ Millions)

Figure 36. Americas Legalized Cannabis Sales Market Share by Country in 2021

Figure 37. Americas Legalized Cannabis Revenue Market Share by Country in 2021

Figure 38. United States Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Legalized Cannabis Sales Market Share by Region in 2021

Figure 43. APAC Legalized Cannabis Revenue Market Share by Regions in 2021

Figure 44. China Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Legalized Cannabis Sales Market Share by Country in 2021

Figure 51. Europe Legalized Cannabis Revenue Market Share by Country in 2021

Figure 52. Germany Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Legalized Cannabis Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Legalized Cannabis Revenue Market Share by Country in 2021

Figure 59. Egypt Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Legalized Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Legalized Cannabis in 2021

Figure 65. Manufacturing Process Analysis of Legalized Cannabis

Figure 66. Industry Chain Structure of Legalized Cannabis

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390